USFDA completes inspections at Solara Active Pharma's Puducherry, Mangalore facility

24 Feb 2020 Evaluate

United States Food and Drug Administration (USFDA) has completed two successful inspections of Solara Active Pharma Science’s state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from February 17 to 21, 2020.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.